Register today to receive your daily dose of health news. Get the latest information delivered to your inbox with our free dailyRx Newsletter!
Connect with the dailyRx social media channels to receive the latest health news and information and to stay up to date on dailyRx promotions!
Stay up to date with the health news that matters most! Choose from a wide selection of dailyRx Headlines™ news feeds and receive the latest headlines directly on your website as soon as news is published.
Explore our wide selection of money-saving coupons for medications and other health-related products.
Save money on your Rx medications with our printable and online medication discount card.
Learn how to reduce your medication costs with discount programs and other valuable savings resources directly from pharmaceutical companies.
Huge advances have been made in the understanding of multiple myeloma. There are a variety of approaches for treating this blood cancer. The trick is to provide what’s best for the individual patient.
Multiple myeloma is a blood cancer that affects nearly 22,000 Americans every year. It develops in mostly older people when plasma cells in the bone marrow grow out of control.
Part of the treatment for especially severe cancers of the blood is to destroy all the cells in the bone marrow that are responsible for making both the good and bad parts of the blood with radiation therapy.
Health Canada, the Canadian version of the U.S. Food & Drug Administration (FDA), has issued an alert regarding the medication REVLIMID (lenalidomide) that's used to treat multiple myeloma.
People living with the blood cancer multiple myeloma typically take two drugs in combination. The problem is these drugs don't work with every person and tend to fade in effectiveness over time.